Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus and Radiotherapy for Neuroendocrine Liver Metastases
NCT02205515Phase 2Completed
- Sponsor
- Sunnybrook Health Sciences Centre
- Start
- Mar 2016
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in Neuroendocrine Neoplasm (NEN), sponsored by Sunnybrook Health Sciences Centre. Started Mar 2016; status: completed.
02
Drugs
everolimus
03
Conditions
Neuroendocrine Neoplasm (NEN)
Beyond the preview
Go deeper on NCT02205515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02205515.